A two‐step enzymatic resolution process for large‐scale production of ( S)‐ and ( R)‐ethyl‐3‐hydroxybutyrate

Abstract An efficient two‐step enzymatic process for production of ( R )‐ and ( S )‐ethyl‐3‐hydroxybutyrate (HEB), two important chiral intermediates for the pharmaceutical market, was developed and scaled‐up to a multikilogram scale. Both enantiomers were obtained at 99% chemical purity and over 96...

Full description

Bibliographic Details
Published in:Biotechnology and Bioengineering
Main Authors: Fishman, Ayelet, Eroshov, Michael, Sheffer Dee‐Noor, Shani, van Mil, Jan, Cogan, Uri, Effenberger, Reinhard
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2001
Subjects:
Online Access:http://dx.doi.org/10.1002/bit.1115
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fbit.1115
https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.1115
id crwiley:10.1002/bit.1115
record_format openpolar
spelling crwiley:10.1002/bit.1115 2024-09-15T17:42:50+00:00 A two‐step enzymatic resolution process for large‐scale production of ( S)‐ and ( R)‐ethyl‐3‐hydroxybutyrate Fishman, Ayelet Eroshov, Michael Sheffer Dee‐Noor, Shani van Mil, Jan Cogan, Uri Effenberger, Reinhard 2001 http://dx.doi.org/10.1002/bit.1115 https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fbit.1115 https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.1115 en eng Wiley http://onlinelibrary.wiley.com/termsAndConditions#vor Biotechnology and Bioengineering volume 74, issue 3, page 256-263 ISSN 0006-3592 1097-0290 journal-article 2001 crwiley https://doi.org/10.1002/bit.1115 2024-07-25T04:23:51Z Abstract An efficient two‐step enzymatic process for production of ( R )‐ and ( S )‐ethyl‐3‐hydroxybutyrate (HEB), two important chiral intermediates for the pharmaceutical market, was developed and scaled‐up to a multikilogram scale. Both enantiomers were obtained at 99% chemical purity and over 96% enantiomeric excess, with a total process yield of 73%. The first reaction involved a solvent‐free acetylation of racemic HEB with vinylacetate for the production of ( S )‐HEB. In the second reaction, ( R )‐enriched ethyl‐3‐acetoxybutyrate (AEB) was subjected to alcoholysis with ethanol to derive optically pure ( R )‐HEB. Immobilized Candida antarctica lipase B (CALB) was employed in both stages, with high productivity and selectivity. The type of butyric acid ester influenced the enantioselectivity of the enzyme. Thus, extending the ester alkyl chain from ethyl to octyl resulted in a decrease in enantiomeric excess, whereas using bulky groups such as benzyl or t ‐butyl, improved the enantioselectivity of the enzyme. A stirred reactor was found unsuitable for large‐scale production due to attrition of the enzyme particles and, therefore, a batchwise loop reactor system was used for bench‐scale production. The immobilized enzyme was confined to a column and the reactants were circulated through the enzyme bed until the targeted conversion was reached. The desired products were separated from the reaction mixture in each of the two stages by fractional distillation. The main features of the process are the exclusion of solvent (thus ensuring high process throughput), and the use of the same enzyme for both the acetylation and the alcoholysis steps. Kilogram quantities of ( S )‐HEB and ( R )‐HEB were effectively prepared using this unit, which can be easily scaled‐up to produce industrial quantities. © 2001 John Wiley & Sons, Inc. Biotechnol Bioeng 74: 256–263, 2001. Article in Journal/Newspaper Antarc* Antarctica Wiley Online Library Biotechnology and Bioengineering 74 3 256 263
institution Open Polar
collection Wiley Online Library
op_collection_id crwiley
language English
description Abstract An efficient two‐step enzymatic process for production of ( R )‐ and ( S )‐ethyl‐3‐hydroxybutyrate (HEB), two important chiral intermediates for the pharmaceutical market, was developed and scaled‐up to a multikilogram scale. Both enantiomers were obtained at 99% chemical purity and over 96% enantiomeric excess, with a total process yield of 73%. The first reaction involved a solvent‐free acetylation of racemic HEB with vinylacetate for the production of ( S )‐HEB. In the second reaction, ( R )‐enriched ethyl‐3‐acetoxybutyrate (AEB) was subjected to alcoholysis with ethanol to derive optically pure ( R )‐HEB. Immobilized Candida antarctica lipase B (CALB) was employed in both stages, with high productivity and selectivity. The type of butyric acid ester influenced the enantioselectivity of the enzyme. Thus, extending the ester alkyl chain from ethyl to octyl resulted in a decrease in enantiomeric excess, whereas using bulky groups such as benzyl or t ‐butyl, improved the enantioselectivity of the enzyme. A stirred reactor was found unsuitable for large‐scale production due to attrition of the enzyme particles and, therefore, a batchwise loop reactor system was used for bench‐scale production. The immobilized enzyme was confined to a column and the reactants were circulated through the enzyme bed until the targeted conversion was reached. The desired products were separated from the reaction mixture in each of the two stages by fractional distillation. The main features of the process are the exclusion of solvent (thus ensuring high process throughput), and the use of the same enzyme for both the acetylation and the alcoholysis steps. Kilogram quantities of ( S )‐HEB and ( R )‐HEB were effectively prepared using this unit, which can be easily scaled‐up to produce industrial quantities. © 2001 John Wiley & Sons, Inc. Biotechnol Bioeng 74: 256–263, 2001.
format Article in Journal/Newspaper
author Fishman, Ayelet
Eroshov, Michael
Sheffer Dee‐Noor, Shani
van Mil, Jan
Cogan, Uri
Effenberger, Reinhard
spellingShingle Fishman, Ayelet
Eroshov, Michael
Sheffer Dee‐Noor, Shani
van Mil, Jan
Cogan, Uri
Effenberger, Reinhard
A two‐step enzymatic resolution process for large‐scale production of ( S)‐ and ( R)‐ethyl‐3‐hydroxybutyrate
author_facet Fishman, Ayelet
Eroshov, Michael
Sheffer Dee‐Noor, Shani
van Mil, Jan
Cogan, Uri
Effenberger, Reinhard
author_sort Fishman, Ayelet
title A two‐step enzymatic resolution process for large‐scale production of ( S)‐ and ( R)‐ethyl‐3‐hydroxybutyrate
title_short A two‐step enzymatic resolution process for large‐scale production of ( S)‐ and ( R)‐ethyl‐3‐hydroxybutyrate
title_full A two‐step enzymatic resolution process for large‐scale production of ( S)‐ and ( R)‐ethyl‐3‐hydroxybutyrate
title_fullStr A two‐step enzymatic resolution process for large‐scale production of ( S)‐ and ( R)‐ethyl‐3‐hydroxybutyrate
title_full_unstemmed A two‐step enzymatic resolution process for large‐scale production of ( S)‐ and ( R)‐ethyl‐3‐hydroxybutyrate
title_sort two‐step enzymatic resolution process for large‐scale production of ( s)‐ and ( r)‐ethyl‐3‐hydroxybutyrate
publisher Wiley
publishDate 2001
url http://dx.doi.org/10.1002/bit.1115
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fbit.1115
https://onlinelibrary.wiley.com/doi/pdf/10.1002/bit.1115
genre Antarc*
Antarctica
genre_facet Antarc*
Antarctica
op_source Biotechnology and Bioengineering
volume 74, issue 3, page 256-263
ISSN 0006-3592 1097-0290
op_rights http://onlinelibrary.wiley.com/termsAndConditions#vor
op_doi https://doi.org/10.1002/bit.1115
container_title Biotechnology and Bioengineering
container_volume 74
container_issue 3
container_start_page 256
op_container_end_page 263
_version_ 1810489617689870336